塞尔宾B1a通过促进CTSG/AMPK/mTOR通路介导的线粒会诱导肝肺综合征
Liang Li1, Jianzhong Li2, Wendeng Li2
1Department of Thoracic Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, 157, Xiwu Road, Xincheng District, Xi'an, 710004, Shaanxi Province, China. Liliang2022_ts@126.com.
在肝肺综合征 (HPS) 中,SerpinB1a蛋白水平升高,并通过破坏线粒细胞衰变来推动疾病的进展. 减少SerpinB1a可能为HPS提供了一个新的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 肺部医学 肺部医学
- 胃肠病学 胃肠病学
背景情况:
- 线粒对于细胞平衡至关重要,并与肺部疾病有关.
- 肝肺综合征 (HPS) 中线粒的机制尚不清楚.
研究的目的:
- 调查SerpinB1a在HPS病变发生中的作用.
- 阐明SerpinB1a影响HPS进展的分子机制.
主要方法:
- 测量了HPS患者的SerpinB1a水平,与氧和相关.
- 利用胆道结合 (CBDL) 诱导的小鼠HPS模型来评估SerpinB1a的淘汰效应.
- 使用肺微血管内皮细胞 (PMVECs) 进行了体外研究,用HPS大鼠血清治疗.
- 研究了SerpinB1a,Cathepsin G (CTSG) 和VEGF/AMPK/mTOR通路之间的相互作用.
主要成果:
- 在HPS患者中,SerpinB1a水平升高与动脉氧和相反相关.
- 在大鼠HPS模型中,SerpinB1a Knockdown减少了肺出血,微血管扩张和肝纤维化.
- 鼠血清诱导PMVECs的病态增殖,迁移和血管生成;SerpinB1a沉默逆转了这些效应.
- 在机械上,SerpinB1a上调了CTSG,激活了VEGF/AMPK/mTOR通路并促进了线粒,导致PMVEC功能障碍.
结论:
- 塞尔B1a在HPS进展中发挥着关键作用,通过通过CTSG/VEGF/AMPK/mTOR轴和线粒促进PMVEC功能障碍.
- 塞尔宾B1a倒置减轻了HPS的进展,这表明它是一个潜在的治疗点.
更多相关视频
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
